Experimental section
1
H NMR was recorded at 300MHz or 400MHz on a Bruker AC-300 or a Bruker DRX-400. 13 C NMR (75 MHz) was recorded on a Bruker AC-300. 31 P NMR spectra were recorded at 121.4 MHz using 85% H 3 PO 4 as an external standard. All spectra were referenced to the signals of the corresponding solvent. Chemical shifts are given in ppm (δ scale) and coupling constants (J) in Hz. High resolution electrospray ionization (ESI) mass spectra were recorded on a Thermo Scientific LTQ Orbitrap XL instrument. HPLC purification was performed using an Äkta™ basic 10/100 system (Amersham Pharmacia Biotech) equipped with a Phenomenex Jupiter semi-preparative RP-HPLC column (5μm, C18, 300Å). 
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Scheme S1. Synthesis of a phenothiazine C-nucleoside analogue
Compound (2)
Compound 1β (2.0 g, 3.5 mmol), was suspended in MeOH/THF (1:1, 40 mL), NaOMe (0.55 g, 10.2 mmol) was added and the reaction was stirred for 12 h. The mixture was concentrated under reduced pressure to approximately 5 mL, and purified by FCC, eluting with CHCl 3 /MeOH (98:2 to 95:5) gave compound 2 (0.83 g, 72% 6, 135.2, 127.5, 127.1, 125.4, 124.8, 123.7, 123.1, 122.5, 114.0, 113.9, 87.2, 79.4, 73.7, 63.4, 43.7, 35.3 
Compound (3)
Compound 2 (645 mg, 2.0 mmol) was suspended in CH 2 Cl 2 (25 mL), and cooled to 0 ˚C. To this suspension was added 2,6-di-tert-butyl-pyridine (0.82 g, 4.0 mmol) and DMT-triflate (1.1 g, 2.4 mmol) in portions. The reaction was stirred at 0 ˚C for 1 h., and stirred at rt until completion (4 h). The mixture was quenched with methanol (2 mL), diluted with CH 2 Cl 2 and the organic phase was washed with saturated aqueous sodium bicarbonate, brine and dried over anhydrous MgSO 4 . Purification by FCC, eluting with hexane/ethyl acetate (90:10 to 20:80 + ~1% NEt 3 ) gave 3 (760 mg, 60%).
1
H NMR (300MHz , CDCl 3 ): δ = 7. 49 -7.47 (m, 2H), 7.38 -7.12 (m, 11H), 6.92 (t, J = 7.5, 1H), 6.87 -6.74 (m, 6H) , 5.09 (dd, J = 5.7, 10.2 Hz, 1H), 4.41 (m, 1H), 4.04 (m, 1H), 3.80 (s, 6H), 3.37 (s, 3H), 3.36 (s, 3H), 2.20 (m, 1H), 2.01 (m, 1H), 1.78 (br s, 1H).
13
C NMR (75 MHz , CDCl 3 ): δ 145. 6, 135.2, 127.5, 127.1, 125.4, 124.8, 123.7, 123.1, 122.5, 114.0, 113.9, 87.2, 79.4, 73.7, 63.4, 43.7, 35.3. 13 C NMR (75 MHz , CDCl 3 ): δ 158. 4, 145.6, 145.0, 144.8, 136.0, 130.0, 128.1, 127.8, 127.3, 127.0, 126.7, 125.2, 124.7, 123.4, 123.2, 122.3, 113.9, 113.7, 113.1, 86.2, 86.1, 79.2, 77.4, 77.0, 76.6, 74.5, 64.5, 55.1, 43.7, 35 
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Compound (4)
To a solution of compound 3 (675 mg, 1.1 mmol) in dry CH 2 Cl 2 (15 mL), cooled to 0 ˚C, was added N,Ndiisopropylethylamine (0.63 mL, 3.5 mmol), followed by 2-cyanoethyl diisopropylethylamine (320 μL, 1.4 mmol). The reaction was removed from the ice-bath and stirred for 1.0 h at rt, diluted with CH 2 Cl 2 and the organic phase was washed with saturated aqueous sodium bicarbonate, brine and dried over anhydrous MgSO 4 , purified by FCC, eluting with hexane/ethyl acetate (80:20 to 60:40 + ~1% NEt 3 ). The resulting oil was dissolved in a minimal amount of CH 2 Cl 2 and precipitated by the addition of hexane (15 mL), the hexane was discarded and the residue was again dissolved in a minimal amount of CH 2 Cl 2 and precipitated by the addition of hexane, the hexane was again discarded and the precipitated compound was dried under reduced pressure to give 4 (745 mg, 81% 4, 145.7, 145.2, 144.9, 136.0, 136.0, 130.1, 128.3, 128.2, 127.7, 127.3, 127.1, 126.7, 125.3, 124.8, 123.5, 123.3, 122.3, 113.9, 113.7, 113.1, 86.1, 85.6, 79.6, 79.6, 76.3, 76.1, 75.9, 75.6, 64.3, 64.2, 58.4, 58.2, 55.2, 43.3, 43.2, 43.1, 43.1, 35.3, 24.6, 24.5, 24.5, 24.37, 20.4, 20.3, 20.2, 20 
UV Melting Curves
UV melting curves were recorded on a Varian Cary 100-Bio UV/VIS spectrophotometer (Varian Inc.), equipped with a Peltier element at 260 nm with a heating/cooling rate of 0.5°C/min. A cooling/heating cycle in the temperature range 10-90 °C was applied. T m values were obtained from the maxima of the first derivatives of the melting curves using WinUV software. To avoid evaporation of the solution, the sample solutions were covered with a layer of dimethylpolysiloxane. All measurements were carried out in a buffer consisting of 10 mM Na 2 HPO 4 , 150 mM NaCl, pH 7.0 at 1.2 μM strand concentration.
CD spectra
CD spectra were measured on a JASCO J-715 spectropolarimeter at the temperature indicated using quartz cuvettes with a path length of 1 cm. All measurements were carried out in a buffer consisting of 10 mM Na 2 HPO 4 , 150 mM NaCl, pH 7.0 at 4.0 μM strand concentration. 
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Irradiation
The irradiation sample was prepared by mixing a duplex (4 M, 10 mM Na-P i -buffer, 150 mM NaCl, pH 7.0) in equimolar solutions of the single strands together and heating them to 90 °C for 5 min. in the dark, cooling to room temperature over night. Samples were deoxygenated by bubbling N 2 for 30 min. through the solution and then irradiated in quartz glass cuvettes (1 cm). Cuvettes with fresh prepared duplexes were placed 6 cm in front of a Sylvania Blacklight (F8 8W T5 BL350 G5) equipped with a glass cut-off filter (wall thickness 3 mm, ≤ 300nm). The cuvettes were ice cooled to maintain the temperature of the irradiated sample at 4 °C. Aliquots (60 l) of the sample solution (1000 l) were taken after 0, 5, 10, 15, 20, 30, 40 , 60 min of irradiation, placed into sterile a container and stored protected from light at room temperature. After withdrawing the last aliquot, all samples were treated with piperidine (6.6 l) and subsequently heated to 90 °C for 30 min., cooled to RT and lyophilized.
Gels
Samples were dissolved in loading buffer (60 l; 900 l of formamide, 100 l EDTA solution pH 8.0) and treated with ultrasound for 3 min. at RT. After sonication samples were heated to 60 °C for 10 min. and loaded (20 l) onto a gel (19:1 acrylamide-bisacrylamide, 20 % w/v, 8 M urea, 100 mM Tris-borate and 20 mM EDTA buffer, pH 8.3). Gels were run at 250 V for 2 h and analyzed using a FLA-3000 Phosphor Imager (Fujifilm). Band intensities were quantified with ImageJ. Yields were determined by dividing the specific fragment area by the total area, where the aliquot without piperidine treatment served as a blank. All experiments were performed in triplicates. 
